Handelsbanken Fonder’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $492K | Buy |
28,900
+1,400
| +5% | +$23.8K | ﹤0.01% | 1257 |
|
2025
Q1 | $537K | Hold |
27,500
| – | – | ﹤0.01% | 1211 |
|
2024
Q4 | $682K | Sell |
27,500
-1,000
| -4% | -$24.8K | ﹤0.01% | 1165 |
|
2024
Q3 | $698K | Buy |
28,500
+10,900
| +62% | +$267K | ﹤0.01% | 1096 |
|
2024
Q2 | $412K | Buy |
17,600
+700
| +4% | +$16.4K | ﹤0.01% | 1241 |
|
2024
Q1 | $558K | Hold |
16,900
| – | – | ﹤0.01% | 1114 |
|
2023
Q4 | $460K | Buy |
16,900
+6,400
| +61% | +$174K | ﹤0.01% | 1192 |
|
2023
Q3 | $253K | Hold |
10,500
| – | – | ﹤0.01% | 1371 |
|
2023
Q2 | $335K | Buy |
10,500
+1,100
| +12% | +$35.1K | ﹤0.01% | 1292 |
|
2023
Q1 | $288K | Hold |
9,400
| – | – | ﹤0.01% | 1312 |
|
2022
Q4 | $368K | Buy |
9,400
+5,000
| +114% | +$196K | ﹤0.01% | 1135 |
|
2022
Q3 | $210K | Buy |
+4,400
| New | +$210K | ﹤0.01% | 1419 |
|
2022
Q2 | – | Sell |
-8,900
| Closed | -$510K | – | 1621 |
|
2022
Q1 | $510K | Hold |
8,900
| – | – | ﹤0.01% | 1196 |
|
2021
Q4 | $709K | Buy |
8,900
+700
| +9% | +$55.8K | ﹤0.01% | 1109 |
|
2021
Q3 | $713K | Hold |
8,200
| – | – | ﹤0.01% | 1109 |
|
2021
Q2 | $1.06M | Buy |
8,200
+1,500
| +22% | +$193K | 0.01% | 889 |
|
2021
Q1 | $536K | Hold |
6,700
| – | – | ﹤0.01% | 1161 |
|
2020
Q4 | $547K | Buy |
+6,700
| New | +$547K | ﹤0.01% | 1112 |
|